Gabriel S. Morris, CFO at Immix Biopharma, Inc. (IMMX), bought 3,300 shares at $1.81 ($6K) on 2024-06-04, disclosed to the SEC on 2024-06-05.
Open-market purchase of $6k IMMX by CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| IMMX | BUY | 2025-06-20 | $5K | — | Filing → |
| IMMX | BUY | 2024-06-10 | $5K | — | Filing → |
| IMMX | BUY | 2024-05-14 | $10K | — | Filing → |